An insightful evening with Smythe House Limited explored how to structure business assets ahead of a sale, emphasizing the importance of early planning amid potential IHT and CGT changes, and discussing practical strategies such as trusts, freezer shares, and tax relief options.
A superbly informative and friendly evening co-hosted with our friends at Smythe House Limited yesterday 🍷 🧀 , examining ways to structure business assets before a sale.
So often, when a business is progressing towards a sale, the focus is on valuation and completion, and considerations around how to protect the asset realised are left as an afterthought.
The message rang loud and clear: when moving capital from a business to a personal portfolio, it should be planned carefully, and most importantly, in advance.
While rumours abound around rises to IHT and CGT in November’s Budget, and we're seeing some business sales racing to complete ahead of time, little will be clarified until the Chancellor speaks.
There is, however, planning to be done:
🔸 Pensions and death benefits will be subject to IHT in April 2027.
🔸 Various trust structures can help spread business assets across a family. Freezer shares offer a potential option.
🔸 Serious consideration needs to be given to planning for if a business owner or major shareholder dies in service.
🔸 Shareholdings held in private companies will come under IHT at 20% from April 2026. This will cause a major headache for businesses at all stages of maturity as the shareholding will most likely need to be sold to release capital for IHT. Leaving businesses exposed to predatory valuations and restructurings.
🔸 While HMRC grants some leniency over the timeframe of IHT payments, in some instances up to 10 years, the interest is now around 8% and punitive.
🔸 Debate also covered roll-over and deferral relief, assessing the effectiveness of SEIS and EIS schemes.
🙏 Thank you again to Smythe House for such a great evening and in particular to kelly morgan and Adam Young.
Thank you all for coming, and if you need more support or advice on any of the above matters, do reach out to us.
Recent Articles

Morphose Capital Partners Launches Morphose Defence & Resilience (MD&R) to Mobilise Strategic Capital and Critical Innovations

Can The Ghost of CGT Past Forecast What's to Come?
Can the Ghost of CGT Past Forecast What's to Come? In our capacity as M&A advisors, we’re often asked what we think will happen to Capital Gains Tax next month (unfortunately, despite all our combined expertise we can’t fully demystify this one). However, a plotted history of CGT since its inception in 1965, not only reveals how different governments have viewed capital wealth generation, it also signals what might just come next......

Introducing Dr Tom McColm
Morphose is delighted to welcome Dr. Tom McColm as an advisor, bringing a powerful mix of academic excellence and commercial expertise in cleantech and deep-tech ventures. His proven track record in developing and scaling innovative technologies will strengthen Morphose’s advisory capabilities in critical infrastructure and defence.





